Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

RGEN

Repligen Corp.

May 03 • 04:00PM ET

167.05

Dollar change +0.74
Percentage change 0.44	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IJH VB VXF VBK IBB IJK FBT VHT IWR

Index	-	P/E	661.85	EPS (ttm)	0.25	Insider Own	7.02%	Shs Outstand	55.77M	Perf Week	0.28%
Market Cap	9.33B	Forward P/E	83.15	EPS next Y	2.01	Insider Trans	-0.74%	Shs Float	51.95M	Perf Month	-3.41%
Income	14.84M	PEG	38.68	EPS next Q	0.33	Inst Own	104.63%	Short Float	8.83%	Perf Quarter	-14.84%
Sales	607.45M	P/S	15.37	EPS this Y	-16.94%	Inst Trans	1.47%	Short Ratio	9.23	Perf Half Y	27.07%
Book/sh	35.29	P/B	4.73	EPS next Y	38.21%	ROA	0.55%	Short Interest	4.59M	Perf Year	2.21%
Cash/sh	13.97	P/C	11.96	EPS next 5Y	17.11%	ROE	0.76%	52W Range	110.45 - 211.13	Perf YTD	-7.09%
Dividend Est.	-	P/FCF	85.22	EPS past 5Y	15.08%	ROI	0.56%	52W High	-20.88%	Beta	1.07
Dividend TTM	-	Quick Ratio	5.24	Sales past 5Y	31.42%	Gross Margin	42.41%	52W Low	51.24%	ATR (14)	6.83
Dividend Ex-Date	-	Current Ratio	6.35	EPS Y/Y TTM	-91.17%	Oper. Margin	5.52%	RSI (14)	45.90	Volatility	4.96% 3.74%
Employees	1783	Debt/Eq	0.37	Sales Y/Y TTM	-21.90%	Profit Margin	2.44%	Recom	1.50	Target Price	204.80
Option/Short	Yes / Yes	LT Debt/Eq	0.33	EPS Q/Q	-92.68%	Payout	0.00%	Rel Volume	0.92	Prev Close	166.31
Sales Surprise	-3.30%	EPS Surprise	-6.98%	Sales Q/Q	-17.14%	Earnings	May 01 BMO	Avg Volume	496.86K	Price	167.05
SMA20	-0.06%	SMA50	-8.01%	SMA200	-2.20%	Trades		Volume	454,946	Change	0.44%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-04-23	Downgrade	The Benchmark Company	Buy → Hold
Jul-20-23	Initiated	Wells Fargo	Overweight	$185
Jul-05-23	Resumed	JP Morgan	Overweight	$220
Mar-28-23	Initiated	The Benchmark Company	Buy	$230
Dec-14-22	Initiated	Deutsche Bank	Hold	$180
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$190
Jul-20-22	Initiated	UBS	Buy	$213
Oct-14-21	Initiated	Exane BNP Paribas	Outperform	$330
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$241
Aug-24-20	Reiterated	H.C. Wainwright	Buy	$151 → $168
Jun-30-20	Reiterated	H.C. Wainwright	Buy	$143 → $151
May-07-20	Reiterated	H.C. Wainwright	Buy	$100 → $143
Mar-23-20	Reiterated	H.C. Wainwright	Buy	$110 → $100
Nov-15-19	Initiated	Stifel	Buy
Nov-01-19	Upgrade	First Analysis Sec	Outperform → Strong Buy	$107 → $110
Oct-15-19	Initiated	SVB Leerink	Outperform	$100
Aug-28-19	Reiterated	First Analysis Sec	Outperform	$95 → $107
Aug-23-19	Resumed	Stephens	Overweight
Jul-22-19	Upgrade	H.C. Wainwright	Neutral → Buy	$110
Dec-17-18	Upgrade	CL King	Neutral → Buy

Show Previous Ratings

May-02-24 11:31AM	UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating (MT Newswires) +5.02%
11:31AM	Repligen Corporation (NASDAQ:RGEN) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:23AM	Repligen (RGEN) Q1 Earnings Miss, Revenues Beat Estimates (Zacks)
03:06AM	Repligen Corp (RGEN) Q1 2024 Earnings Call Transcript Highlights: Navigating Market Shifts and ... (GuruFocus.com)
May-01-24 11:53AM	RGEN Stock Earnings: Repligen Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
09:11AM	Loading…
09:11AM	Repligen Corp (RGEN) Q1 2024 Earnings: A Close Alignment with Analyst Projections (GuruFocus.com)
08:50AM	Repligen (RGEN) Misses Q1 Earnings Estimates (Zacks)
08:47AM	Repligen's Q1 Adjusted Earnings, Revenue Fall (MT Newswires)
07:47AM	Repligen: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-23-24 11:43AM	Should be Confident in Repligen Corporation (RGEN)'s Long-Term Growth Potential? (Insider Monkey) +8.76%
Apr-17-24 07:30AM	Repligen to Report First Quarter 2024 Financial Results (GlobeNewswire)
Apr-12-24 10:07AM	Artisan Mid Cap Fund Trimmed Repligen Corporation (RGEN) after Share Appreciation (Insider Monkey)
09:49AM	Should You Sell Pool Corporation (POOL)? (Insider Monkey)
Mar-19-24 07:30AM	Repligen Appoints Maggie A. Pax to Board of Directors (GlobeNewswire)
01:18AM	Loading…
Mar-12-24 01:18AM	Repligen Corp CEO Anthony Hunt Sells 16,707 Shares (GuruFocus.com)
Feb-27-24 02:02AM	Repligen Corp COO James Bylund Sells 4,373 Shares (GuruFocus.com)
Feb-24-24 12:03AM	Decoding Repligen Corp (RGEN): A Strategic SWOT Insight (GuruFocus.com)
Feb-22-24 11:24AM	Repligen Corporation (NASDAQ:RGEN) Q4 2023 Earnings Call Transcript (Insider Monkey)
10:39AM	Repligen (RGEN) Stock Down on Q4 Earnings Miss, Revenues Fall Y/Y (Zacks)
Feb-21-24 08:45AM	Repligen (RGEN) Lags Q4 Earnings and Revenue Estimates (Zacks)
08:12AM	Repligen Corp (RGEN) Reports Decline in 2023 Revenue and Net Income (GuruFocus.com)
07:51AM	Repligen: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-07-24 07:30AM	Repligen to Report Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Jan-31-24 12:10PM	Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jan-29-24 05:09AM	Strength Seen in Repligen (RGEN): Can Its 4.3% Jump Turn into More Strength? (Zacks)
Dec-19-23 07:30AM	Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-18-23 04:49AM	Here's Why Repligen Corporation (RGEN) Rose 13% in Q3 (Insider Monkey)
Dec-07-23 07:30AM	Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements (GlobeNewswire)
11:31AM	Loading…
Nov-30-23 11:31AM	Repligen (RGEN) Up 21.3% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-15-23 07:15AM	Does Repligen Corp. (RGEN) Have a Bright Future? (Insider Monkey)
Nov-14-23 02:01PM	UPDATE Repligen Announces Publication of the Company's 2022 Sustainability Report (GlobeNewswire) +5.55%
07:30AM	Repligen Announces Publication of the Company's 2022 Sustainability Report (GlobeNewswire)
Nov-07-23 07:30AM	Repligen Corporation to Present at Upcoming Investor Conferences (GlobeNewswire)
Nov-02-23 07:30AM	Repligen Launches TangenX SC as First-to-Market Holder-Free Self-Contained TFF Device (GlobeNewswire)
Nov-01-23 12:10PM	Repligen Corporation (NASDAQ:RGEN) Q3 2023 Earnings Call Transcript (Insider Monkey)
11:46AM	Repligen (RGEN) Shares Rise on Q3 Earnings & Revenue Beat (Zacks)
12:04AM	Q3 2023 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-31-23 09:41AM	Repligen Corp (RGEN) Reports Q3 2023 Earnings: Revenue Down 30% Y/Y (GuruFocus.com) +17.86%
09:12AM	Repligen Q3 Results Top Estimates; Boosts FY23 Earnings Outlook (RTT News)
08:50AM	Repligen (RGEN) Tops Q3 Earnings and Revenue Estimates (Zacks)
07:41AM	Repligen: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance (GlobeNewswire)
Oct-25-23 10:01AM	Analysts Estimate Exelixis (EXEL) to Report a Decline in Earnings: What to Look Out for (Zacks) -10.99%
Oct-24-23 10:00AM	Earnings Preview: Repligen (RGEN) Q3 Earnings Expected to Decline (Zacks)
Oct-17-23 11:44AM	Repligen (RGEN)'s Hidden Value: An In-Depth Analysis of Its Market Worth (GuruFocus.com)
07:30AM	Repligen to Report Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-02-23 07:30AM	Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer (GlobeNewswire)
Sep-27-23 06:51AM	Repligen (RGEN) to Acquire Fluid Management Company Metenova (Zacks)
Sep-26-23 12:41PM	Waltham's Repligen to acquire Swedish firm (American City Business Journals)
07:30AM	Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova (GlobeNewswire)
Sep-14-23 10:10AM	Moderna (MRNA) Surges 3.2%: Is This an Indication of Further Gains? (Zacks)
Sep-12-23 07:30AM	Repligen Appoints Jason K. Garland as Chief Financial Officer (GlobeNewswire)
Sep-06-23 03:06AM	Reasons For the Decline of Repligen Corporation (RGEN) (Insider Monkey)
Sep-01-23 12:19PM	Drug Developer Stocks Are Risky. Why a Picks-and-Shovels Approach Makes Sense. (Barrons.com)
11:31AM	Why Is Repligen (RGEN) Up 2.9% Since Last Earnings Report? (Zacks)
07:30AM	Repligen Corporation to Present at Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-21-23 06:53AM	What Makes Repligen Corporation (RGEN) a Quality Investment? (Insider Monkey)
Aug-17-23 08:00AM	Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process Intensification (GlobeNewswire)
Aug-10-23 09:39AM	Multiple Headwinds Impacted Repligen Corp. (RGEN)s Performance in Q2 (Insider Monkey)
Aug-09-23 06:10AM	News Flash: 14 Analysts Think Repligen Corporation (NASDAQ:RGEN) Earnings Are Under Threat (Simply Wall St.)
Aug-03-23 11:19AM	Repligen (RGEN) Beats on Q2 Earnings, Lowers '23 Guidance (Zacks)
Aug-02-23 08:55AM	Repligen (RGEN) Q2 Earnings Surpass Estimates (Zacks)
07:49AM	Repligen: Q2 Earnings Snapshot (AP Finance)
07:30AM	Repligen Reports Second Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance (GlobeNewswire)
Jul-31-23 09:08AM	What Does Repligen Corporation's (NASDAQ:RGEN) Share Price Indicate? (Simply Wall St.)
Jul-26-23 10:02AM	Earnings Preview: Repligen (RGEN) Q2 Earnings Expected to Decline (Zacks)
Jul-25-23 11:40AM	EXEL or RGEN: Which Is the Better Value Stock Right Now? (Zacks)
Jul-20-23 10:01AM	Estee Lauder downgraded, AB InBev upgraded: Wall Street's top analyst calls (The Fly)
Jul-19-23 07:30AM	Repligen to Report Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-10-23 08:34AM	Are Options Traders Betting on a Big Move in Repligen (RGEN) Stock? (Zacks)
Jun-30-23 10:54AM	Repligen's (NASDAQ:RGEN) five-year total shareholder returns outpace the underlying earnings growth (Simply Wall St.)
Jun-21-23 08:00PM	RGEN: Lowering target price to $157.00 (Argus Research)
Jun-07-23 11:30AM	Why Is CRISPR Therapeutics AG (CRSP) Up 1.8% Since Last Earnings Report? (Zacks)
Jun-02-23 11:31AM	Qiagen (QGEN) Down 0.6% Since Last Earnings Report: Can It Rebound? (Zacks)
Jun-01-23 11:31AM	Why Is Repligen (RGEN) Up 2.7% Since Last Earnings Report? (Zacks)
May-31-23 07:30AM	Repligen Corporation to Present at Upcoming Investor Conferences (GlobeNewswire)
May-30-23 12:09PM	If EPS Growth Is Important To You, Repligen (NASDAQ:RGEN) Presents An Opportunity (Simply Wall St.)
May-09-23 05:52PM	Repligen Corporation (NASDAQ:RGEN) Q1 2023 Earnings Call Transcript (Insider Monkey)
May-03-23 01:20PM	Repligen (RGEN) Beats on Q1 Earnings, Lowers 2023 Guidance (Zacks)
May-02-23 11:36PM	Q1 2023 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
08:55AM	Repligen (RGEN) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:52AM	Repligen: Q1 Earnings Snapshot (AP Finance)
07:30AM	Repligen Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance (GlobeNewswire)
07:02AM	Is Repligen Corporation (RGEN) a Best-In-Class Stock in Terms of Growth and Profitability? (Insider Monkey)
May-01-23 07:43AM	Should Weakness in Repligen Corporation's (NASDAQ:RGEN) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? (Simply Wall St.)
Apr-26-23 08:00PM	RGEN: Lowering target price to $156.00 (Argus Research)
10:02AM	Will AnaptysBio, Inc. (ANAB) Report Negative Q1 Earnings? What You Should Know (Zacks)
Apr-25-23 02:07PM	Why Repligen Stock Is Sinking Today (Motley Fool) -11.09%
10:01AM	Repligen (RGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release (Zacks)
Apr-18-23 07:30AM	Repligen to Report First Quarter 2023 Financial Results (GlobeNewswire)
Apr-11-23 02:41PM	A Look At The Fair Value Of Repligen Corporation (NASDAQ:RGEN) (Simply Wall St.)
Mar-24-23 11:30AM	Why Is Repligen (RGEN) Down 11.4% Since Last Earnings Report? (Zacks)
Mar-14-23 07:30AM	Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum (GlobeNewswire)
Feb-23-23 06:28PM	Repligen Corporation (NASDAQ:RGEN) Q4 2022 Earnings Call Transcript (Insider Monkey) +8.02%
01:41PM	Repligen's (RGEN) Q4 Earnings and Revenues Beat Estimates (Zacks)
05:54AM	Repligen Full Year 2022 Earnings: EPS Beats Expectations (Simply Wall St.)
Feb-22-23 08:55AM	Repligen (RGEN) Q4 Earnings and Revenues Surpass Estimates (Zacks)
07:30AM	Repligen Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KURIYEL RALF	Senior VP, R&D	Mar 11 '24	Option Exercise	86.10	1,271	109,433	27,777	Mar 12 08:24 PM
KURIYEL RALF	Senior VP, R&D	Mar 11 '24	Sale	193.73	3,517	681,348	24,260	Mar 12 08:24 PM
Hunt Anthony	Chief Executive Officer	Mar 08 '24	Option Exercise	16.55	1	17	201,956	Mar 11 07:43 PM
Hunt Anthony	Chief Executive Officer	Mar 08 '24	Sale	197.44	16,707	3,298,632	185,249	Mar 11 07:43 PM
DAWES KAREN A	Director	Feb 27 '24	Option Exercise	42.07	4,626	194,616	88,367	Feb 28 09:56 PM
DAWES KAREN A	Director	Feb 27 '24	Sale	193.35	1,000	193,350	87,367	Feb 28 09:56 PM
Bylund James	Chief Operating Officer	Feb 23 '24	Option Exercise	94.33	940	88,670	18,508	Feb 26 08:38 PM
Bylund James	Chief Operating Officer	Feb 23 '24	Sale	198.08	4,373	866,204	14,135	Feb 26 08:38 PM
Gebski Christine	See Remarks	Nov 10 '23	Sale	147.13	3,788	557,328	28,787	Nov 13 05:10 PM
DAWES KAREN A	Director	Aug 29 '23	Option Exercise	18.12	7,392	133,943	84,591	Aug 30 04:06 PM
DAWES KAREN A	Director	Aug 29 '23	Sale	171.38	850	145,673	83,741	Aug 30 04:06 PM
Madaus Martin D	Director	May 08 '23	Buy	156.18	500	78,090	1,611	May 08 09:15 PM

Open in Screener

QTRX

Quanterix Corp

May 03 • 04:00PM ET

17.02

Dollar change +0.10
Percentage change 0.59	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN IBB VTWO VHT SCHA DFAC DFAS

Index	RUT	P/E	-	EPS (ttm)	-0.86	Insider Own	9.52%	Shs Outstand	38.01M	Perf Week	9.38%
Market Cap	651.02M	Forward P/E	-	EPS next Y	-0.90	Insider Trans	-0.10%	Shs Float	34.61M	Perf Month	-21.20%
Income	-32.33M	PEG	-	EPS next Q	-0.31	Inst Own	83.72%	Short Float	3.20%	Perf Quarter	-26.32%
Sales	122.37M	P/S	5.32	EPS this Y	-16.11%	Inst Trans	-7.34%	Short Ratio	2.96	Perf Half Y	-20.62%
Book/sh	9.13	P/B	1.86	EPS next Y	9.96%	ROA	-7.41%	Short Interest	1.11M	Perf Year	3.78%
Cash/sh	8.40	P/C	2.03	EPS next 5Y	-	ROE	-9.16%	52W Range	12.25 - 29.70	Perf YTD	-37.75%
Dividend Est.	-	P/FCF	-	EPS past 5Y	9.72%	ROI	-8.42%	52W High	-42.69%	Beta	1.51
Dividend TTM	-	Quick Ratio	9.26	Sales past 5Y	28.48%	Gross Margin	54.70%	52W Low	38.94%	ATR (14)	1.07
Dividend Ex-Date	-	Current Ratio	9.84	EPS Y/Y TTM	67.16%	Oper. Margin	-41.56%	RSI (14)	38.01	Volatility	6.21% 5.74%
Employees	441	Debt/Eq	0.12	Sales Y/Y TTM	15.96%	Profit Margin	-26.42%	Recom	1.40	Target Price	28.40
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	34.58%	Payout	-	Rel Volume	0.98	Prev Close	16.92
Sales Surprise	5.70%	EPS Surprise	-5.10%	Sales Q/Q	22.17%	Earnings	May 07 AMC	Avg Volume	373.65K	Price	17.02
SMA20	-2.26%	SMA50	-22.66%	SMA200	-28.08%	Trades		Volume	367,414	Change	0.59%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-01-24	Initiated	Scotiabank	Sector Outperform	$30
Sep-25-23	Upgrade	Canaccord Genuity	Hold → Buy	$25 → $32
Aug-08-23	Upgrade	SVB Securities	Market Perform → Outperform	$30
May-23-23	Upgrade	Goldman	Neutral → Buy	$13 → $27
Aug-15-22	Downgrade	Canaccord Genuity	Buy → Hold	$40 → $12
Aug-09-22	Downgrade	SVB Leerink	Outperform → Mkt Perform	$35 → $15
Aug-09-22	Downgrade	Cowen	Outperform → Market Perform	$38 → $18
Mar-02-22	Upgrade	Goldman	Sell → Neutral	$40
Oct-15-21	Resumed	Cowen	Outperform
Jun-04-21	Initiated	Goldman	Sell	$53

Apr-29-24 04:00PM	Quanterix To Report First Quarter 2024 Financial Results (Business Wire)
11:13AM	Canaccord Genuity Adjusts Price Target on Quanterix to $25 From $32, Maintains Buy Rating (MT Newswires)
Mar-21-24 05:30PM	Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer's Disease Testing Infrastructure (Business Wire)
Mar-06-24 09:50AM	Quanterix (QTRX) AD Offering Gets FDA's Breakthrough Device Tag (Zacks)
Mar-04-24 09:00AM	Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimers Disease (Business Wire)
08:16AM	Loading…
Mar-03-24 08:16AM	Quanterix Corporation (NASDAQ:QTRX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 09:26AM	Q4 2023 Quanterix Corp Earnings Call (Thomson Reuters StreetEvents) +12.69%
Feb-29-24 05:10PM	Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023 (Business Wire)
Feb-27-24 10:03AM	Quanterix (QTRX) Expands in Alzheimer's Testing With Alliances (Zacks)
06:34AM	Quanterix Corp (QTRX) Aligns Earnings Release with Annual Report Filing, Reaffirms 2023 Guidance (GuruFocus.com)
Feb-26-24 09:00AM	Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimers Disease (Business Wire)
Feb-23-24 04:30PM	Quanterix to Present at Cowens 44th Annual Health Care Conference (Business Wire)
Feb-16-24 04:00PM	Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call (Business Wire)
Dec-12-23 04:00PM	Quanterix to Present at 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
12:00PM	Loading…
Dec-04-23 12:00PM	Here's Why Quanterix Corporation (QTRX) is a Great Momentum Stock to Buy (Zacks)
Nov-29-23 09:55AM	Does Quanterix Corporation (QTRX) Have the Potential to Rally 33.74% as Wall Street Analysts Expect? (Zacks)
Nov-13-23 04:00PM	Quanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (Business Wire)
09:55AM	Wall Street Analysts See a 54.88% Upside in Quanterix Corporation (QTRX): Can the Stock Really Move This High? (Zacks)
07:00AM	Sotera Health Appoints Karen Flynn to Board of Directors (GlobeNewswire)
Nov-08-23 12:22PM	Quanterix Corporation (NASDAQ:QTRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-06-23 05:40PM	Quanterix Corp (QTRX) Raises Full-Year Revenue Expectations Following Q3 2023 Results (GuruFocus.com)
05:30PM	7 Stocks to Buy if You Anticipate a Hot November (InvestorPlace)
04:50PM	Quanterix Releases Operating Results for Third Quarter 202 (Business Wire)
Nov-02-23 10:00AM	Analysts Estimate National Vision (EYE) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-30-23 04:00PM	Quanterix to Report Third Quarter 2023 Financial Results on November 7, 2023 (Business Wire)
Oct-24-23 04:30PM	Quanterix Launches High Accuracy p-Tau 217 Blood Biomarker Test to Aid Physician Diagnosis of Alzheimers Disease (Business Wire) +10.36%
Oct-23-23 08:30PM	Quanterix Announces New Agreement to Advance Blood Based Alzheimer's Disease Detection (Business Wire)
Oct-03-23 12:36PM	Quanterix (QTRX): A Closer Look at Its Modestly Undervalued Status (GuruFocus.com)
Sep-29-23 08:32AM	Zimmer Biomet (ZBH) Gains From ROSA Sales Growth Amid FX Woes (Zacks)
05:00PM	Loading…
Sep-28-23 05:00PM	Quanterix CEO to Speak at Goldman Sachs Alzheimers Disease Day (Business Wire)
10:37AM	Abbott (ABT) Rides on Nutrition Recovery Amid Low Testing Sales (Zacks)
09:45AM	Quanterix Corporation (QTRX) Moves 7.2% Higher: Will This Strength Last? (Zacks)
Sep-27-23 11:40AM	Quanterix Corp (QTRX): An In-Depth Look at Its Undervalued Status (GuruFocus.com) +7.16%
07:51AM	Here's Why Investors Should Retain STERIS (STE) Stock for Now (Zacks)
07:47AM	Here's Why You Should Buy Align Technology (ALGN) Stock Now (Zacks)
Sep-21-23 09:42AM	Here's Why Investors Should Buy Alcon (ALC) Stock Right Now (Zacks)
Sep-15-23 08:21AM	Here's Why You Should Retain Insulet (PODD) Stock for Now (Zacks)
Sep-13-23 08:16AM	Here's Why You Should Invest in Edward Lifesciences (EW) Now (Zacks)
Sep-06-23 10:04AM	Here's Why You Should Retain Omnicell (OMCL) Stock Now (Zacks)
09:48AM	Why You Should Add Haemonetics (HAE) to Your Portfolio Now (Zacks)
Sep-05-23 08:00AM	Quanterix to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference (Business Wire)
Aug-31-23 08:37AM	Here's Why You Should Retain Integra (IART) Stock for Now (Zacks)
Aug-30-23 09:32AM	Here's Why You Should Retain Zimmer Biomet (ZBH) for Now (Zacks)
Aug-25-23 10:26AM	Integra (IART) CSS Sales Aid, Boston Recall Hurts Growth (Zacks)
09:34AM	BioSig (BSGM) Grows in Arrhythmia Care With Subscription Model (Zacks)
09:14AM	Thermo Fisher's (TMO) EXTENT Solution Makes Commercial Launch (Zacks)
09:04AM	Here's Why You Should Retain Tandem Diabetes (TNDM) Now (Zacks)
Aug-21-23 04:30PM	William P. Donnelly Appointed to Quanterixs Board of Directors (Business Wire)
Aug-09-23 08:30AM	Quanterix Appoints Vandana Sriram as Chief Financial Officer (Business Wire)
Aug-07-23 07:40PM	Quanterix Corporation (QTRX) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -5.03%
05:13PM	Quanterix Releases Operating Results for Second Quarter 2023 (Business Wire)
Aug-03-23 08:00AM	Quanterix to Present at Canaccord Genuity 43rd Annual Growth Conference (Business Wire) -5.68%
Jul-31-23 08:00AM	Quanterixs Simoa® Technology Powers Large, International Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Neurological Disease Activity in Pediatric Patients (Business Wire) +6.43%
Jul-26-23 11:29AM	Here's Why We're Not Too Worried About Quanterix's (NASDAQ:QTRX) Cash Burn Situation (Simply Wall St.)
Jul-20-23 08:00AM	Quanterix to Report Second Quarter 2023 Financial Results on August 8, 2023 (Business Wire)
Jul-10-23 11:08AM	Quanterix (QTRX) Advances in Alzheimer's Diagnosis With LucentAD (Zacks)
02:01AM	Quanterix Corporation (QTRX) Surges 13.6%: Is This an Indication of Further Gains? (Zacks)
Jul-06-23 05:37PM	Quanterix Launches LucentAD Biomarker Blood Test to Aid Physician Diagnosis of Alzheimers Disease in Patients (Business Wire)
Jun-29-23 09:35AM	Bullish Quanterix Insiders Loaded Up On US$5.6m Of Stock (Simply Wall St.)
Jun-07-23 04:00PM	Quanterix to Participate in Fireside Chat at Goldman Sachs Annual Global Healthcare Conference (Business Wire)
May-24-23 02:27AM	4 big analyst picks: Sherwin-Williams a buy at Jefferies on firming housing market (Investing.com)
May-16-23 11:01AM	Shareholders in Quanterix (NASDAQ:QTRX) are in the red if they invested three years ago (Simply Wall St.)
May-10-23 06:52AM	Q1 2023 Quanterix Corp Earnings Call (Thomson Reuters StreetEvents)
May-09-23 05:15PM	Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Quanterix Releases Operating Results for First Quarter 2023 (Business Wire)
May-04-23 11:20AM	Quanterix Corporation (QTRX) Soars 33.7%: Is Further Upside Left in the Stock? (Zacks) +12.13%
May-02-23 04:30PM	Quanterixs First Quarter 2023 Earnings Conference Call (Business Wire)
Apr-25-23 04:30PM	FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials (Business Wire) -7.23%
Apr-17-23 08:20AM	Investors Holding Back On Quanterix Corporation (NASDAQ:QTRX) (Simply Wall St.)
Mar-08-23 04:30PM	Quanterix to Participate in Barclays Global Healthcare Conference (Business Wire)
07:21AM	Quanterix Corporation (NASDAQ:QTRX) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-07-23 12:42AM	Q4 2022 Quanterix Corp Earnings Call (Thomson Reuters StreetEvents) -5.52%
Mar-06-23 09:35AM	Quanterix Corporation (QTRX) Reports Q4 Loss, Misses Revenue Estimates (Zacks) +12.13%
08:09AM	Quanterix Releases Operating Results for Fourth Quarter and Full Year 2022; Aligned with Expectations (Business Wire)
Feb-28-23 04:30PM	Quanterix to Present at Cowens 43rd Annual Health Care Conference (Business Wire)
Feb-27-23 02:03PM	Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call (Business Wire)
Feb-16-23 10:13AM	We're Not Very Worried About Quanterix's (NASDAQ:QTRX) Cash Burn Rate (Simply Wall St.)
Jan-20-23 08:20AM	Bullish Quanterix Corporation (NASDAQ:QTRX) insiders filled their treasuries with US$5.6m worth of stock over last year (Simply Wall St.)
Jan-09-23 04:30PM	Quanterix Announces Appointment of Brian Blaser to Board of Directors (Business Wire)
08:30AM	Quanterix Expands Laboratory Developed Test Menu with Launch of Neurofilament Light Chain Test (Business Wire)
Jan-03-23 04:00PM	Quanterix to Present at 41st Annual J.P. Morgan Healthcare Conference (Business Wire) -7.15%
Dec-05-22 04:36PM	Quanterixs Simoa® Technology Drives Advances in Alzheimers Disease Research Presented at 2022 Clinical Trials on Alzheimers Disease (CTAD) Conference (Business Wire)
Nov-16-22 04:30PM	Quanterix to Participate in the 15th Clinical Trials on Alzheimers Disease (CTAD) Task Force (Business Wire)
Nov-10-22 04:30PM	Quanterix to Participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum (Business Wire) +24.02%
06:13AM	Quanterix Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
Nov-08-22 05:15PM	Quanterix Corporation (QTRX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Quanterix Corporation Releases Operating Results for Third Quarter 2022 (Business Wire)
Nov-01-22 04:30PM	Quanterix Third Quarter 2022 Earnings Conference Call (Business Wire)
Sep-09-22 10:34AM	Here's Why We're Not Too Worried About Quanterix's (NASDAQ:QTRX) Cash Burn Situation (Simply Wall St.) +8.49%
Sep-07-22 09:55AM	Wall Street Analysts Predict a 73% Upside in Quanterix Corporation (QTRX): Here's What You Should Know (Zacks) +9.35%
Aug-22-22 11:45AM	Quanterix Corp - Insiders Are Buying Near All-Time Lows (GuruFocus.com)
Aug-13-22 08:37AM	Insider Buying: The Quanterix Corporation (NASDAQ:QTRX) Independent Director Just Bought 1,498% More Shares (Simply Wall St.)
Aug-11-22 09:35AM	Quanterix Corporation (QTRX) Loses 53.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) +18.69%
Aug-10-22 06:04PM	Why Quanterix Stock Bounced Back on Wednesday (Motley Fool) +14.75%
Aug-09-22 06:28PM	Why Quanterix Shares Plunged by Nearly 55% Today (Motley Fool) -54.76%
Aug-08-22 05:45PM	Quanterix Corporation (QTRX) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -5.61%
04:02PM	Quanterix Announces the Resignation of Kevin Hrusovsky as Executive Chairman of Board of Directors (Business Wire)
04:01PM	Quanterix Corporation Releases Operating Results for Second Quarter 2022, Announces Business Re-Alignment Plan and Revises 2022 Guidance (Business Wire)
Aug-03-22 04:30PM	Quanterix to Participate in the Canaccord Genuity 42nd Annual Growth Conference (Business Wire) +6.77%

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
OLSON LAURIE J	Director	Apr 01 '24	Option Exercise	12.86	1,000	12,860	16,238	Apr 02 04:00 PM
OLSON LAURIE J	Director	Apr 01 '24	Sale	23.50	1,000	23,500	15,238	Apr 02 04:00 PM
OLSON LAURIE J	Director	Feb 14 '24	Sale	24.35	1,500	36,525	15,238	Feb 15 05:52 PM
OLSON LAURIE J	Director	Jan 02 '24	Option Exercise	12.86	1,000	12,860	17,738	Jan 04 04:09 PM
OLSON LAURIE J	Director	Jan 02 '24	Sale	26.91	1,000	26,910	16,738	Jan 04 04:09 PM
DONNELLY WILLIAM P	Director	Sep 08 '23	Buy	24.85	20,200	501,978	28,438	Sep 11 04:07 PM
MEISTER PAUL M	Director	Jun 07 '23	Option Exercise	2.89	23,335	67,438	287,970	Jun 08 04:25 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

RGEN

Repligen Corp.

QTRX

Quanterix Corp

Upgrade your FINVIZ experience